Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 8,954 shares at $120.03 ($1.1M) on 2021-01-25, disclosed to the SEC on 2021-01-27.
Open-market sale of $1.1M NBIX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.03 | 1,600 | $192K | 17.9% |
| 2 | $120.03 | 3,477 | $417K | 38.8% |
| 3 | $120.03 | 3,477 | $417K | 38.8% |
| 4 | $120.00 | 100 | $12K | 1.1% |
| 5 | $120.00 | 300 | $36K | 3.3% |
| Total | $120.03 avg | 8,954 |
| $1.1M |
| 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |